Jan 9 (Reuters) - Iceland-based biotechnology firm Decode Genetics Inc reported positive results from a mid-stage trial of its drug, DG051, to prevent heart attacks. The study showed that patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results